Home › Shire to Combine with Baxalta in Deal Valued at About $32 Billion
 

Keywords :   


Shire to Combine with Baxalta in Deal Valued at About $32 Billion

2016-01-11 14:23:03| Biotech - Topix.net

Shire Plc agreed to buy Baxalta Inc. for about $32 billion to become the world's biggest maker of so-called orphan drugs for rare diseases. The price includes 0.1482 of Shire's American depositary receipts and $18 in cash for each Baxalta share held, the Dublin-based drugmaker said in a statement.

Tags: deal billion combine valued

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »